Onkos Surgical Announces First FDA De Novo Approval of an Antibacterial Coating for Tumor and Revision Orthopaedic Implants

PRWeb
This post was originally published on this site

– Bacterial contamination of orthopaedic implants is a growing clinical challenge that burdens the healthcare system and can lead to dangerous, potentially fatal complications for patients. PARSIPPANY, N.J., April 8, 2024 /PRNewswire/ — Onkos Surgical, an orthopaedic company founded to…